Blog
Every guide we've published — organised by topic.
GLP-1 Science
Evidence-based explanations of GLP-1, semaglutide, appetite regulation, and modern obesity science.
Sleep Quality on Semaglutide: What Patients Report
Better sleep is among the most-reported quality-of-life changes on semaglutide. Some of it is weight-mediated; some of it appears to be direct.
Foods to Avoid on GLP-1 Medications (and Why They Trigger Side Effects)
Slowed gastric emptying makes some foods feel worse than others. The list isn't long, but it's specific.
Not Losing Weight on Ozempic? 7 Reasons and What to Try
STEP 1 average: 14.9% loss at 68 weeks. But the range was wide — some lost over 25%, some less than 5%. Here are the most common explanations for being on the lower end of that distribution.
GLP-1 Side Effects Timeline: Week-by-Week What to Expect
Most side effects cluster in the first 4–8 weeks and improve as the body adapts. Knowing the timing — what tends to peak when, what tends to resolve when — changes the experience of going through it.
Building a High-Protein Meal Plan While on a GLP-1
Reduced appetite makes hitting protein targets harder. A practical framework: density over volume, simple repeatable meals, and protein-first sequencing.
GLP-1 Maintenance Dosing: What Long-Term Use Looks Like
Most patients on semaglutide for obesity reach the 2.4 mg maintenance dose. What that looks like at two years, what dose-reduction options exist, and what STEP 5 revealed about the second year of treatment.
How to Stop a GLP-1 Without Regaining the Weight: An Evidence Review
STEP 4 and SURMOUNT-4 are clear about what discontinuation looks like at the population level. But individual outcomes vary, and the available data offer modest guidance on what shifts the curve.
GLP-1 Medications and Alcohol: What Science Actually Says
Patients on semaglutide consistently report they want alcohol less. The mechanism likely overlaps with food reward — and a clinical trial in alcohol use disorder is underway.
How GLP-1 Medications Affect Emotional Eating: What Patients Report
Beyond hunger reduction, semaglutide and tirzepatide users describe something specific: emotional eating loses its pull. Here's what the trials measured and what the mechanism likely is.
Weight Loss Plateau on Semaglutide: Causes and What to Do
Plateaus happen — and aren't necessarily a failure. STEP 1 data shows when the curve flattens for most patients, and what causes it.
Strength Training on Ozempic: How to Preserve Muscle Mass
A 2024 MRI sub-study of STEP 1 patients found ~40% of total weight loss came from lean tissue. Resistance training and adequate protein change that ratio.
Setting Realistic Weight Loss Goals on a GLP-1
STEP 1 averaged 14.9% body weight loss at 68 weeks. SURMOUNT-1 averaged 20.9%. Trial averages hide a wide individual range — and the endpoint thinking that surrounds weight goals tends to mislead more than it helps.
Exercise on GLP-1 Medications: Building a Routine That Works
Lower appetite and slower gastric emptying change how you fuel a workout. Combined with the lean-tissue arithmetic of any large weight loss, exercise priorities reshuffle in ways that aren't obvious from pre-GLP-1 fitness advice.
What to Eat on a GLP-1: A Practical Daily Guide
Slowed gastric emptying changes what works in your meals. The principles that help: protein first, fewer big meals, no greasy bombs. Here's a practical guide.
GLP-1 Medications and Binge Eating Disorder: The Emerging Evidence
Binge eating disorder affects more adults than anorexia and bulimia combined. The first RCTs testing GLP-1 medications specifically for BED have begun reporting — and the results are reframing how clinicians think about treatment.
Ozempic Face: Why It Happens and What Helps
Rapid weight loss produces visible facial changes that have been visible since long before semaglutide — but now they have a brand name attached. The mechanism, the timeline, and what actually mitigates it.
Hair Loss on Semaglutide: Causes, Timeline, and Prevention
Telogen effluvium is the medical name. It's not unique to semaglutide — it follows almost any major caloric deficit or weight loss event. Here's why, when it appears, and what reverses it.
Semaglutide Explained: What It Is, How It Works, and Who It's For
Semaglutide is the most studied GLP-1 receptor agonist in existence. Here's a plain-language breakdown of its mechanism, approved uses, and what the clinical evidence actually shows.
How GLP-1 Affects Appetite: The Brain-Gut Mechanism Explained
GLP-1 suppresses appetite through two distinct pathways — one in the gut, one in the brain. Understanding both explains why GLP-1 medications feel different from dieting.
GLP-1 vs. Traditional Weight Loss: What's Actually Different
GLP-1 medications produce weight loss through mechanisms that conventional dieting simply cannot replicate. Here's why the biology is fundamentally different — and why that matters.
Semaglutide Brand Names: Ozempic, Wegovy, and Rybelsus Explained
One molecule, three brand names, two routes of administration, and completely different coverage rules depending on which you are prescribed. Here is how Ozempic, Wegovy, and Rybelsus relate to each other — and when each is used.
The Complete List of FDA-Approved GLP-1 Medications in 2026
There are more FDA-approved GLP-1 medications than most people realise — and they differ significantly in mechanism, dosing, approved uses, and availability. Here is the full picture.
How Semaglutide Works for Weight Loss: The Full Picture
Semaglutide does not simply suppress appetite. It reshapes the hormonal environment around eating — slowing digestion, quieting food-focused brain activity, and improving insulin response simultaneously. Here is the full mechanism.
How Tirzepatide Works: The Dual GLP-1/GIP Mechanism Explained
Tirzepatide activates two receptors instead of one — GLP-1 and GIP. The combination produces more weight loss than GLP-1 agonism alone, but the mechanism behind the GIP component is still being worked out. Here is what we know.
GLP-1 vs GIP: What the Difference Means for Your Weight Loss
Tirzepatide acts on two receptors — GLP-1 and GIP. Understanding what GIP does, and how the combination changes results, helps explain why the dual agonists have outperformed single-target drugs in trials.
What Is a GLP-1 Medication? The Complete Overview
GLP-1 medications have become the most talked-about drugs in weight management — but what exactly are they, who are they for, and how do they fit into a broader treatment plan?
What Is GLP-1? A Plain-Language Guide to How These Medications Work
GLP-1 stands for glucagon-like peptide-1 — a hormone your gut produces naturally after every meal. Understanding what it does, and how medications mimic it, explains almost everything about why these drugs work.
GLP-1 Myths vs. Facts: Cutting Through the Noise
From 'it's the easy way out' to 'you'll gain it all back' — a clear-eyed look at the claims that dominate GLP-1 conversations.
Metabolism
Articles about metabolism, insulin resistance, energy balance, metabolic adaptation, and weight regulation.
Adaptive Thermogenesis: Why Your Metabolism Slows When You Diet
Lose 10% of your body weight and your resting metabolic rate falls by more than the smaller body would predict. That gap has a name — and three decades of research mapping how it works.
Is 'Metabolic Damage' Real? What the Research Actually Says
Adaptive thermogenesis is documented and persistent. 'Permanent metabolic damage' is mostly myth. The distinction matters because it changes what someone with a long dieting history can reasonably expect.
Why 'Eat Less, Move More' Doesn't Work for Most People
The calories-in, calories-out model isn't wrong — it's dangerously incomplete. Here's what actually happens to your metabolism, hunger, and energy when you try to follow it.
Is Slow Metabolism Real? What the Research Actually Shows
Most people attribute weight gain to a slow metabolism. The science is more nuanced — true metabolic rate differences between individuals are smaller than commonly believed, but they're real.
Energy Balance and Weight Regulation: Beyond Calories In, Calories Out
The 'calories in, calories out' model is technically correct but practically incomplete. Your body actively adjusts both sides of the equation in response to what you eat — and that changes everything.
Metabolic Adaptation: Why Your Body Fights Back Against Weight Loss
During calorie restriction, the body systematically reduces energy expenditure — often by more than the lost tissue accounts for. This adaptive thermogenesis is a primary reason weight loss plateaus and rebounds.
Insulin Resistance Explained: Causes, Effects, and What to Do
Insulin resistance is one of the most common metabolic dysfunctions — and one of the least understood by people who have it. Here's what the science shows about causes, consequences, and interventions.
Preserving Muscle While You Lose Weight on a GLP-1
Rapid weight loss without a plan costs you muscle. Two levers — resistance training and protein — protect the body composition you actually want.
Protein on a GLP-1: How Much, and Why It Matters So Much
When appetite drops, protein is the first thing to fall off the plate — and the one macro you can least afford to lose. Here's how to hit your target.
Fatigue and Dehydration on a GLP-1: An Underrated Pair
Tiredness on a GLP-1 is often blamed on the drug itself — when the real culprits are under-eating and not drinking enough. Here's how to tell the difference.
Appetite & Hunger
Science-backed insights into hunger, satiety, cravings, and appetite hormones.
Carb Cravings vs. Sugar Cravings vs. Fat Cravings: Why They Feel Different
Carb cravings tend to follow serotonin dips. Fat cravings track caloric restriction. Sugar cravings reflect dopamine loops. Each has a different driver — and each responds to different things.
Boredom Eating vs. Emotional Eating: How to Tell the Difference
Boredom eating is an external-cue problem. Emotional eating is an internal-cue problem. They look similar from the outside, but they have different drivers — and different treatments.
Why Cravings Get Worse at Night — and What Your Body Is Doing
Circadian biology, an evening cortisol dip, melatonin's effect on insulin, and elevated reward sensitivity after dark all converge on the same pattern: cravings climb in the evening.
Why You're Hungry Again an Hour After Eating
If you eat at noon and you're hungry by 1:30pm, that's not a willpower issue. It's the difference between caloric intake and satiety signaling — and the two can be entirely disconnected.
Does Hunger Go Away? What Happens to Appetite After Years of Dieting
The honest answer: usually, no. The hunger normalization data tells a more nuanced story — and it's central to why obesity is treated as a chronic disease.
Why Calorie Restriction Makes You Hungrier Over Time
The hunger you feel in week 8 of a diet isn't just the same hunger as week 1 — there's more of it. The hormonal explanation has been replicated across multiple study designs.
The Psychology of Food Obsession: Why Some Brains Think About Food Constantly
The Minnesota Starvation Experiment volunteers, formerly indifferent to food, began dreaming about it. Modern brain imaging shows the same pattern in dieting subjects today.
How to Feel Fuller on Fewer Calories: What the Evidence Actually Supports
Three evidence-based strategies. Protein preloading. Fibre-first eating. High-volume foods. Each has measurable effects on satiety — and limits worth understanding.
Why Some Foods Fill You Up and Others Leave You Wanting More
The Satiety Index ranked 38 foods against white bread. Boiled potatoes scored over 300. Croissants scored 47. Here's what's actually driving those numbers.
Why Ultra-Processed Food Doesn't Fill You Up
Kevin Hall's 2019 NIH trial controlled for calories, protein, fat, sugar, fibre, and sodium between ultra-processed and unprocessed diets. Participants on the UPF arm spontaneously ate 508 more calories per day.
Why You Never Feel Full: Leptin Resistance and What It Means
Many people with obesity have high leptin levels — not low. The hypothalamus has stopped responding to the signal. This is leptin resistance, and it's the mechanism behind chronic overeating.
Stress Eating and Cortisol: The Biology Behind Why You Reach for Food
Cortisol raises blood glucose, drives cravings for calorie-dense food, and blunts satiety signaling. The mechanism has been mapped — and it explains the post-deadline ice cream perfectly.
Am I an Emotional Eater? Signs, Science, and What to Do Next
The Dutch Eating Behavior Questionnaire distinguishes emotional, restrained, and external eating patterns. Identifying which one you do most changes what actually helps.
Why You Eat When You're Not Hungry: The Emotion-Food Connection
Eating in response to stress, sadness, or boredom isn't a defect of self-control. It's a learned coping response that engages real neurochemistry — and one that's biologically reinforced.
Sugar Cravings After Every Meal: Why It Happens and How to Stop It
The 60-to-90-minute window after refined carbohydrates has a name in glucose research. The mechanism is reproducible, the fix is structural, and the reason willpower keeps failing is the same reason the craving keeps arriving.
"Food Noise": What It Is, Why It Happens, and How to Turn It Down
The term went viral on TikTok in 2023. The phenomenon has been documented in clinical literature since the 1950s. Here's what food noise actually is — and why a generation of patients suddenly had vocabulary for something they had lived with for years.
Why Food Cravings Feel Impossible to Resist (It's Not Willpower)
Cravings activate the same dopamine system as addictive drugs. The pull you feel toward food at 11pm isn't a moral failing — it's an ancient reward circuit working as designed in a world it never evolved for.
The Hunger Hormone Ghrelin: Why Your Body Fights Every Diet
Ghrelin is the only known peripheral hormone that increases hunger. After dieting, it rises 20–30% above baseline and stays elevated — for years.
Why Am I Always Hungry No Matter How Much I Eat?
You ate a full meal — so why does your brain still want more? The answer involves three hormones, a hypothalamus that lost its calibration, and a food environment your biology was never designed for.
The Satiety Hormones: GLP-1, PYY, and CCK Explained Simply
Three gut hormones tell your brain a meal is enough. When they fire correctly, eating naturally stops. When they don't, you're hungry an hour later. Here's how each one works.
How GLP-1 Medications Quiet Food Cravings: The Brain Science
Patients on semaglutide often describe something unexpected: food stops feeling urgent. Scientists now understand why — and it starts in the brain, not the stomach.
Food Cravings Explained: Why Your Brain Demands Specific Foods
Cravings aren't hunger. They're a distinct neurological phenomenon driven by dopamine, memory, and sensory conditioning. Here's the science behind why certain foods feel compulsive.
The Science of Satiety: How Your Body Knows When to Stop Eating
Satiety is a multi-layered biological signal — not a single switch. Understanding how the gut, hormones, and brain coordinate to end a meal explains why some people stop naturally and others don't.
Why You Feel Hungry All the Time: The Hormonal Explanation
Persistent hunger isn't a willpower problem — it's a hormonal one. Here's how ghrelin, leptin resistance, and energy sensing drive chronic hunger in people with obesity.
Hunger Hormones Explained: Ghrelin, Leptin, Insulin, and GLP-1
Four hormones do most of the work regulating when, how much, and why you eat. Understanding ghrelin, leptin, insulin, and GLP-1 explains why appetite is so hard to control through willpower alone.
How to Manage GLP-1 Nausea Without Quitting
Nausea is the number one reason people stop early — and it's also the most manageable side effect. Here's what actually helps, ranked by how well it works.
GLP-1 Medications and Mental Health: What We Know
Mood, motivation, and 'food noise' are all part of the GLP-1 conversation. Here's a careful look at what's reported, what's studied, and what to watch for.
Your First Month on a GLP-1: A Week-by-Week Guide
The first four weeks set the tone. Here's a realistic timeline of what most people feel, when appetite changes show up, and the mistakes worth avoiding early.
Weight Loss Research
Breakdowns of modern obesity research, clinical studies, and emerging metabolic science.
Set Point Theory: Does Your Body Have a Defended Weight?
The phrase "set point" is technically imprecise — researchers prefer "defended range" — but the underlying observation is well-supported. Across fifty years of starvation studies, twin research, and modern hormonal trials, bodies push back when their weight is moved.
Yo-Yo Dieting (Weight Cycling): Health Risks and How to Break the Cycle
Repeated cycles of loss and regain are independently associated with visceral fat redistribution, higher cardiovascular risk, and metabolic dysregulation — beyond the effects of obesity itself. The data make a quiet case for sustained treatment over repeated attempts.
Weight Regain After Stopping Ozempic: What the Research Actually Shows
STEP 4 randomised people who had already lost weight on semaglutide to either continue or switch to placebo. The placebo group regained two-thirds of their loss within a year — and the biology behind that pattern explains the rest.
Keto, Paleo, Intermittent Fasting — Why Popular Diets Don't Last
DIETFITS, A TO Z, PREDIMED. Long-term head-to-head diet trials reveal a stubborn pattern: at 12 months, the differences between approaches are smaller than the differences between adherent and non-adherent individuals.
The All-or-Nothing Diet Trap: Why Restriction Always Leads to Overeating
Cognitive restraint theory predicts what dieters call "falling off the wagon" with mechanistic precision. The abstinence violation effect was named in 1985 — and explains why "starting over Monday" almost never works.
Why Low-Calorie Diets Backfire Long-Term
CALERIE trial data: 25% caloric restriction for two years. The participants lost weight. Then a quieter finding emerged about what their bodies did to compensate.
Why Most People Regain Weight After a Diet — and Why It's Not Your Fault
Most people regain the weight they lose within five years. That statistic isn't evidence of weak willpower — it's evidence of powerful biology defending a weight your body considers its normal.
Why Diets Fail: The Biology Your Doctor Never Explained
Weight regain after dieting isn't a willpower failure — it's a predictable biological response involving hormones, metabolism, and brain chemistry. The science has been clear for decades.
I've Tried Every Diet and Nothing Works: What Your Body Is Actually Doing
You've counted calories, cut carbs, tried fasting. The weight keeps coming back. This isn't a willpower problem — it's a predictable biological response that most doctors never explain.
GLP-1 Clinical Studies Explained: How to Read the Research
STEP 1, SURMOUNT-1, SCALE — the major GLP-1 trials are frequently cited but rarely explained. Here's what these studies measured, what the numbers mean, and how to evaluate the evidence.
Sustainable Weight Management: What the Long-Term Research Shows
Short-term weight loss is achievable for most people. What separates those who maintain it from those who regain? Research points to specific biological, behavioral, and pharmacological predictors.
The Future of Obesity Science: What's Coming After GLP-1
GLP-1 medications represent a genuine breakthrough in obesity treatment — but the field is moving fast. Here's what researchers are working on next, from dual agonists to central neural targets.
Why Most Diets Fail Long-Term: The Biology of Weight Regain
About 80% of diet-induced weight loss is regained within five years. This isn't a motivation problem — it's biology. Here's what the research shows about why weight regain is so predictable.
How Much Weight Can You Lose on Semaglutide? Real Trial Data
The clinical trials show average weight loss of around 15% of body weight on Wegovy. But averages conceal wide individual variation — understanding what actually drives results is more useful than a single headline number.
GLP-1 for Weight Loss vs. Diabetes: Same Drug, Different Rules
Ozempic and Wegovy contain the same molecule at different doses. So do Mounjaro and Zepbound. But the indication changes everything — coverage, criteria, cost, and what your prescriber can offer.
Who Qualifies for a GLP-1 Prescription? BMI, Conditions & Criteria
The eligibility criteria for a GLP-1 prescription depend on which drug, which indication, and whether you're going through insurance or paying out of pocket. Here's exactly what you need to know.
Planning for Life After a GLP-1: The Maintenance Question
The hardest part of GLP-1 treatment isn't starting — it's deciding what comes next. Why the maintenance conversation should start on day one.
Modern Treatments
Educational content about modern weight management approaches and GLP-1-based therapies.
Zepbound Clinical Trial Results: What SURMOUNT-1 Through 5 Tell Us
SURMOUNT-1 reported 20.9% mean body weight loss at 72 weeks. SURMOUNT-3 enrolled lifestyle-resistant patients. SURMOUNT-4 measured what happens after discontinuation. Here is the full picture from the program.
Using Mounjaro for Weight Loss Without Diabetes: What You Need to Know
Mounjaro and Zepbound contain the same molecule but carry different FDA indications. The distinction shapes prescribing, insurance coverage, and the clinical context of off-label use.
Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
SURMOUNT-1 and STEP 1 ran similar protocols. The headline numbers favor tirzepatide. The clinical picture is more nuanced.
GLP-1 Medications vs Bariatric Surgery: When Each Makes Sense
Two interventions for severe obesity, with overlapping but not identical roles. The choice isn't binary — and patients increasingly do both.
Micro-Dosing GLP-1: What the Trend Is and What the Science Says
Compounded pharmacies and biohackers have popularised sub-clinical doses of semaglutide for weight maintenance, side-effect mitigation, and 'metabolic optimisation.' The clinical literature on what this actually does is thin — and worth reading carefully.
Compounded Semaglutide vs. Brand Wegovy: Is It the Same Drug?
Compounded semaglutide contains the same active molecule as Wegovy — but it is not the same product. The distinction between them affects quality assurance, regulatory oversight, legal status, and price. Here is what you need to know.
Mounjaro vs. Zepbound: What Changed and What Didn't
Mounjaro and Zepbound contain the same drug at the same doses. What changed is the FDA label — and that single difference controls your insurance coverage, your savings card eligibility, and which prescription your doctor writes.
Tirzepatide Brand Names: Mounjaro vs. Zepbound — Which to Ask For
Mounjaro and Zepbound are both tirzepatide at the same doses. The brand you ask for determines your coverage — and getting this wrong can mean paying thousands more per year for an identical drug.
Semaglutide Dosing Schedule: 0.25mg to 2.4mg Week by Week
Semaglutide has two dosing protocols depending on whether you are taking Ozempic or Wegovy. The titration schedule exists for a specific reason — and rushing it is one of the most common mistakes people make.
Semaglutide Injection Sites: Where and How to Inject
Semaglutide is injected subcutaneously — into the fatty tissue just under the skin — at one of three approved sites. Using the right technique and rotating sites properly makes the process faster, more comfortable, and more consistent.
Ozempic vs. Wegovy: Same Drug, Different Purposes
Ozempic and Wegovy both contain semaglutide, yet they are not interchangeable. The distinction between the two shapes everything from your insurance coverage to the maximum dose your prescriber can offer.
Wegovy Cost Without Insurance in 2025
The list price for Wegovy runs over $1,300 per month — but almost nobody pays that. Here is what Wegovy actually costs in 2025 across every realistic payment path.
Ozempic Savings Card: How to Pay $25/Month
Novo Nordisk's Ozempic savings card can reduce your monthly cost to $25 — but eligibility rules catch a lot of people off guard. Here is exactly how it works and who qualifies.
Best Telehealth for GLP-1 Prescriptions in 2025
The telehealth GLP-1 market is large, crowded, and uneven in quality. Here is a plain-language framework for evaluating providers — and the questions that actually separate good clinical care from a slick checkout page.
Ozempic Price Without Insurance: What You'll Actually Pay
Ozempic's list price is around $935 per month, but that is rarely what people pay. Here is a straightforward breakdown of what Ozempic costs through every realistic route in 2025.
Can You Get a GLP-1 Without an In-Person Doctor Visit?
Most people starting GLP-1 medications today never set foot in a doctor's office to get their prescription. Here's how telehealth works, what the process actually involves, and what to watch out for.
Semaglutide vs. Tirzepatide: How the Two Big Drugs Compare
They're the two most-discussed GLP-1 medications, but they aren't the same drug. Here's a plain-language comparison of mechanism, results, and trade-offs.
How to Choose a GLP-1 Telehealth Provider Without Getting Burned
The telehealth market is crowded, and not all providers are equal. A practical checklist for separating real clinical care from a slick checkout page.
What GLP-1 Medications Actually Cost — and How to Pay Less
List prices are eye-watering, but very few people pay them. Here's how insurance, savings cards, and compounding change the real number.
GLP-1 Injection Day: Small Habits That Make It Easier
The weekly injection is simple once it's routine. A short, practical guide to timing, sites, storage, and the little things that smooth it out.